Multi-omics profiling implicates gut microbiota-sphingolipid interplay in the neuroprotective effects of semaglutide on diabetic cognitive impairment
BackgroundThe gut microbiome is a critical regulator of host health, but how it mediates the therapeutic effects of drugs targeting neurodegenerative diseases like diabetic cognitive impairment (DCI) is unclear. Here, we investigated whether the neuroprotective effects of the GLP-1 agonist semagluti...
Gardado en:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-03-01
|
| Series: | Frontiers in Microbiology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fmicb.2026.1705784/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|